Alpha 2.0
Login Register
» Articles » PMID: 1125623

Untoward Effects Associated with Practolol Administration: Oculomucocutaneous Syndrome

Overview
Journal Br Med J
Specialty General Medicine
Date 1975 Mar 15
PMID 1125623
Citations 54
Authors
P Wright
Affiliations
Soon will be listed here.
Abstract

Keratoconjunctivitis sicca, conjunctival scarring, fibrosis, metaplasia, and shrinkage developed in 27 patients as an adverse reaction to practolol. Rashes, nasal and mucosal ulceration, fibrous or plastic peritonitis, pleurisy, cochlear damage, and secretory otitis media also occurred in some cases. Three patients suffered profound visual loss though most retained good vision. Symptoms and signs improved on withdrawal of the drug, but reduction of tear secretion persisted in most patients.

Citing Articles

Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity.

Ferner R, Stevens R, Anton C, Aronson J Drug Saf. 2022; 45(2):137-144.

PMID: 35064899 PMC: 8783592. DOI: 10.1007/s40264-021-01138-z.

Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.

Shah R Drug Saf Case Rep. 2017; 4(1):11.

PMID: 28933008 PMC: 5607154. DOI: 10.1007/s40800-017-0053-0.

Lost in Translation (LiT): IUPHAR Review 6.

Dollery C Br J Pharmacol. 2014; 171(9):2269-90.

PMID: 24428732 PMC: 3997269. DOI: 10.1111/bph.12580.

Intelligent risk communication: can it be improved?.

Czarnecki A Drug Saf. 2007; 31(1):1-6.

PMID: 18095742 DOI: 10.2165/00002018-200831010-00001.

Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.

Shakir S, Layton D Drug Saf. 2002; 25(6):467-71.

PMID: 12071785 DOI: 10.2165/00002018-200225060-00012.

References
1.
Jones B . The ocular diagnosis of benign mucous membrane pemphigoid. Proc R Soc Med. 1961; 54:109-10. View
2.
Hughes G . Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971; 2(7729):861-3. DOI: 10.1016/s0140-6736(71)90234-0. View
3.
Raftery E, DENMAN A . Systemic lupus erythematosus syndrome induced by practolol. Br Med J. 1973; 2(5864):452-5. PMC: 1589475. DOI: 10.1136/bmj.2.5864.452. View
4.
Felix R, IVE F, Dahl M . Cutaneous and ocular reactions to practolol. Br Med J. 1974; 4(5940):321-4. PMC: 1612905. DOI: 10.1136/bmj.4.5940.321. View
5.
Amos H, Brigden W, McKerron R . Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue. Br Med J. 1975; 1(5958):598-600. PMC: 1672842. DOI: 10.1136/bmj.1.5958.598. View